Get the Stockscreener App
1.59
0.63%
0.01
Pre-market:
1.60
0.01
+0.63%
Waldencast Plc stock is traded at $1.59, with a volume of 61,828.
It is up +0.63% in the last 24 hours and down -13.11% over the past month.
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
See More
Previous Close:
$1.58
Open:
$1.59
24h Volume:
61,828
Relative Volume:
0.79
Market Cap:
$197.09M
Revenue:
-
Net Income/Loss:
$-11.05M
P/E Ratio:
-6.106
EPS:
-0.2604
Net Cash Flow:
$2.18M
1W Performance:
-7.56%
1M Performance:
-13.11%
6M Performance:
+0.00%
1Y Performance:
-52.68%
1-Day Range:
$1.57
$1.6345
1-Week Range:
$1.57
$1.84
52-Week Range:
$1.45
$3.5399
Waldencast Plc Stock (WALD) Company Profile
Name
Waldencast Plc
Sector
Industry
Phone
(917) 546-6828
Address
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, EL, KVUE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.59 | 195.85M | 0 | -11.05M | 2.18M | -0.2604 |
|
PG
Procter Gamble Co
|
158.30 | 371.19B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
69.07 | 151.09B | 56.67B | 6.96B | 7.39B | 3.1175 |
|
CL
Colgate Palmolive Co
|
95.28 | 76.56B | 20.38B | 2.26B | 3.63B | 2.6214 |
|
EL
Estee Lauder Cos Inc
|
99.21 | 35.71B | 14.67B | -178.00M | 1.14B | -0.5002 |
|
KVUE
Kenvue Inc
|
18.19 | 34.79B | 15.12B | 1.47B | 1.72B | 0.764 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-26 | Resumed | Jefferies | Buy |
| Nov-25-25 | Downgrade | Telsey Advisory Group | Outperform → Market Perform |
| Apr-22-25 | Initiated | Alliance Global Partners | Buy |
| Dec-16-24 | Initiated | TD Cowen | Hold |
| Oct-25-24 | Initiated | Canaccord Genuity | Buy |
| May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
| Jul-24-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Waldencast Plc Stock (WALD) Latest News
Quarterly Trades: Can Waldencast plc Equity Warrant navigate macro headwindsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
WALD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WALD Should I Buy - Intellectia AI
Schweiger clinics to trial new Obagi injectable in real-world ALOHA program - Stock Titan
New Highs: Is Waldencast plc Equity Warrant stock a value trapEarnings Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Guidance Update: Can Waldencast plc Equity Warrant outperform in the next rallyFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Obagi Medical and It's a Secret Med Spa announce collaboration in the Aloha program - marketscreener.com
Luxury med spa chain to evaluate Obagi’s new ALOHA hyaluronic injectable - Stock Titan
Does Waldencast plc Equity Warrant have a sustainable dividendIPO Watch & Weekly Return Optimization Alerts - mfd.ru
Will Waldencast plc Equity Warrant face regulatory challengesMarket Sentiment Summary & Weekly Breakout Stock Alerts - mfd.ru
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism - Yahoo Finance
Earnings Report: Can Waldencast plc Equity Warrant navigate macro headwindsLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - MSN
Waldencast outlines mid-teens revenue growth for 2025 backed by brand expansion - MSN
Downgrade Watch: Can Waldencast plc Equity Warrant outperform in the next rallyTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Obagi Medical and Aesthetic Record Announce Collaboration - GlobeNewswire
How Obagi is testing a new hyaluronic acid injectable in real clinics - Stock Titan
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Is Waldencast plc stock positioned well for digital economy2025 Major Catalysts & Reliable Price Action Trade Plans - mfd.ru
Is Waldencast plc likely to announce a buybackQuarterly Market Summary & Free Verified High Yield Trade Plans - mfd.ru
Is Waldencast plc stock resilient to inflationMarket Growth Review & Real-Time Volume Analysis Alerts - mfd.ru
Is Waldencast plc Equity Warrant stock a value trapJuly 2025 Update & High Conviction Trade Alerts - mfd.ru
Why analysts remain bullish on Waldencast plc Equity Warrant stockJuly 2025 Earnings & Fast Gaining Stock Reports - mfd.ru
Is Waldencast plc Equity Warrant stock a top momentum play2025 Price Momentum & Weekly High Momentum Picks - mfd.ru
Waldencast: Strategic Reviews Are More Than Necessary (NASDAQ:WALD) - Seeking Alpha
Why Waldencast plc stock attracts high net worth investorsQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
WALDWaldencast plc Latest Stock News & Market Updates - Stock Titan
Dividend Watch: What is the long term forecast for Waldencast plc stockMarket Risk Report & Community Shared Stock Ideas - baoquankhu1.vn
How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes - Yahoo Finance UK
Obagi Medical names DermFx as partner for hyaluronic acid program - Investing.com South Africa
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
SoCal med spa DermFx to evaluate Obagi MagIQ injectable in daily practice - Stock Titan
Obagi Medical and DermFx Announce Collaboration in the - GlobeNewswire
Retail Surge: Is Waldencast plc Equity Warrant a strong growth stockMarket Activity Recap & Verified Technical Trade Signals - baoquankhu1.vn
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
Obagi Medical and Moxie Announce Collaboration in the ALOHA - GlobeNewswire
Aug Technicals: Will Waldencast plc benefit from rising consumer demandMarket Risk Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect - Finviz
New Obagi two-step lip peel aims for smoother, protected lips - Stock Titan
How strong is Waldencast plc Equity Warrant stock revenue growth2025 Major Catalysts & Smart Swing Trading Techniques - mfd.ru
US Market Wrap: Is Waldencast plc Equity Warrant a strong growth stock2025 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Waldencast PLC (NASDAQ:WALD) Short Interest Down 25.7% in January - MarketBeat
VIO Med Spa to test Obagi MagIQ filler in nationwide clinics - Stock Titan
Obagi Medical and VIO Med Spa Announce Collaboration in the - GlobeNewswire
Inside Obagi’s plan to test a new injectable across Next Health wellness centers - Stock Titan
Obagi Medical and Next Health Announce Collaboration in the - GlobeNewswire
UPDATEObagi Medical and Alpha Aesthetic Partners - GlobeNewswire
Obagi filler to be studied across 31 Alpha medspa locations - stocktitan.net
Obagi Medical and Alpha Aesthetic Partners Announce Their - GlobeNewswire
Published on: 2026-01-27 01:38:51 - baoquankhu1.vn
Waldencast Plc Stock (WALD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.47%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):